Frontline Medical Sciences and Pharmaceutical Journal (FMSPJ) is a fully Open Access, peer-reviewed international journal dedicated to the free and unrestricted dissemination of scientific knowledge. The journal believes that research should be accessible to researchers, healthcare professionals, educators, policymakers, and the public worldwide without financial, legal, or technical barriers.
All articles published in the journal are made freely available online immediately upon publication. Readers may access, read, download, copy, distribute, print, search, and link to the full text of articles without requesting prior permission from the publisher or authors, provided that proper attribution is given to the original work.
Open Access Statement
Frontline Medical Sciences and Pharmaceutical Journal provides immediate and permanent open access to all published content in accordance with the principle that making research freely available supports a greater global exchange of knowledge and promotes scientific advancement.
The journal does not impose subscription fees or access restrictions on readers.
Creative Commons License
All articles published in Frontline Medical Sciences and Pharmaceutical Journal are distributed under the:
Creative Commons Attribution 4.0 International License (CC BY 4.0)
Under this license, users are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, including commercial use.
Provided that:
- Appropriate credit is given to the original author(s).
- A link to the license is provided.
- Any changes made are clearly indicated.
This license promotes maximum dissemination, visibility, and reuse of scholarly research while ensuring proper attribution to authors.
Double-Blind Peer Review
To ensure the quality, integrity, and scientific validity of published research, all manuscripts submitted to the journal undergo a rigorous Double-Blind Peer Review Process through the Open Journal Systems (OJS) platform.
Under this process:
- Authors do not know the identities of reviewers.
- Reviewers do not know the identities of authors.
- Editorial decisions are based solely on academic merit and scientific quality.
- Confidentiality is maintained throughout the review process.
The double-blind review system helps ensure fairness, objectivity, and impartial evaluation of all submissions.
Author Rights
Authors retain copyright of their published work while granting the journal the right to publish, archive, index, and distribute the article.
Authors may:
- Share their published articles on personal websites.
- Deposit articles in institutional repositories.
- Archive articles in subject repositories.
- Distribute articles for educational and research purposes.
- Use published content in future scholarly works with proper citation.
Archiving and Preservation
The journal is committed to the long-term preservation and accessibility of scholarly content. Published articles remain permanently available through the journal website and associated indexing and archiving services.
Benefits of Open Access
Open Access publication provides several advantages:
- Greater visibility and readership.
- Increased citation potential.
- Faster dissemination of research findings.
- Worldwide accessibility without subscription barriers.
- Enhanced collaboration among researchers and institutions.
- Improved public access to scientific knowledge.
Commitment to Knowledge Sharing
Frontline Medical Sciences and Pharmaceutical Journal supports the global movement toward open science and unrestricted access to scholarly research. By combining rigorous double-blind peer review with an open-access publishing model and Creative Commons licensing, the journal promotes transparency, accessibility, innovation, and the advancement of medical and pharmaceutical sciences worldwide.
License: Creative Commons Attribution 4.0 International (CC BY 4.0)